Epstein-Barr virus (EBV) has been implicated in the pathogenesis of ac
quired immunodeficiency syndrome- (AIDS) related primary central nervo
us system (CNS) lymphoma. Tumors from 16 patients with AIDS-related pr
imary CNS lymphoma, and 1 with concurrent CNS and systemic lymphoma, w
ere evaluated histologically and for the presence of EBV by immunohist
ochemistry for latent membrane protein, in situ hybridization for EBER
1 RNA transcripts, polymerase chain reaction (PCR) for the single cop
y EBNA1 gene, and PCR for the multiple copy EBV internal repeat region
. Histologically, 11 tumors displayed extremely large, bizarre, anapla
stic immunoblasts, with prominent nucleoli and multilobated nuclei, re
sembling Reed-Stemberg (RS) cells and variants. The lymphomas displaye
d B cell phenotypes by immunohistochemistry. Latent membrane protein w
as detected in 88% (15/117) of tumors, EBNA1 sequences in 54% (6/1 1),
EBV-internal repeat sequences in 100% (11/11), and EBER1 transcripts
in 100% (17/17). All EBNA1-negative tumors lacked RS-like cells. Laten
t membrane protein immunohistochemical staining was limited to a minor
ity of tumor cells, and was most often positive in RS-like, immunoblas
tic large cells. In situ hybridization for EBER1 message demonstrated
EBV in the majority of tumor cells, which displayed a wide range of si
zes and variable nuclear morphology. We conclude that EBV can be detec
ted in all AIDS-related primary CNS lymphomas, and that EBER1 in situ
hybridization is currently the best technique for detecting virus. The
presence of atypical immunoblasts (RS-like cells) with high levels of
latent membrane protein in many of these tumors may suggest the emerg
ence of a common, virally-determined phenotype in AIDS-related Lymphom
as of brain.